Medical ConditionsBleeding & blood: Neuroblastoma and sympathetic nervous system tumors
Medical ConditionsBleeding & blood: Neuroblastoma and sympathetic nervous system tumors
Neuroblastoma and sympathetic nervous system tumors
Overview
Board takeaway: Coordinate oral assessment and infection control with oncology before treatment, then track blood counts, mucositis, and dental-development effects.
What is neuroblastoma and how does it differ from other sympathetic tumors?
Neuroblastoma arises from immature sympathetic nerve cells, often in the adrenal gland or sympathetic chain. It mainly affects infants and young children. Ganglioneuroblastoma and ganglioneuroma have different degrees of maturation and behavior; they are not interchangeable diagnoses.
Which findings can suggest neuroblastoma?
An abdominal, neck, or chest mass, bone pain, orbital prominence or bruising, neurologic weakness, or Horner syndrome may occur. Some tumors produce catecholamine-related symptoms. Diagnosis requires medical evaluation, imaging, and tumor assessment; an oral or facial sign alone does not establish malignancy.
What dental effects can follow neuroblastoma treatment?
Chemotherapy, radiation, and transplantation can cause mucositis, infection or bleeding vulnerability, taste changes, and dry mouth. Treatment during development can alter enamel, tooth size or number, root growth, and eruption. Hearing loss or other late effects can change communication and follow-up needs.
How should dental care be coordinated with neuroblastoma treatment?
- Before therapy: assess and prioritize odontogenic infection, nonrestorable teeth, periodontal disease, and sources of trauma within the oncology timetable.
- During therapy: use current immune and hematologic status, expected nadir, and the planned procedure to decide timing and support; elective care may need deferral.
- Urgent needs: coordinate infection, pain, bleeding, and procedural coverage with oncology rather than applying one count as automatic clearance.
- After therapy: continue prevention and assess salivary, developmental, growth, and functional late effects.
What treatments and prognostic distinctions matter in neuroblastoma?
Risk-directed treatment can include observation, surgery, chemotherapy, radiation, stem cell rescue, differentiation therapy, or immunotherapy. Low- and intermediate-risk disease often has a favorable outlook, while high-risk disease needs intensive treatment. The child's actual protocol and complications determine oral-care priorities.